Pharmacological studies of 1-phenacyl-2,3-dimethyl-3-(3-hydroxyphenyl) piperidine hydrochloride (TA-306), an analgesic and antitussive agent.
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000996:Antitussive Agents / Q000494:pharmacology*; D001463:Barbiturates / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D004285:Dogs; D004357:Drug Synergism; D007421:Intestine, Small / Q000187:drug effects; D008297:Male; D008614:Meperidine / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009269:Nalorphine / Q000037:antagonists & inhibitors; D010880:Piperidines / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000996:Antitussive Agents; D001463:Barbiturates; D010880:Piperidines; D009020:Morphine; D008614:Meperidine; D009269:Nalorphine